4 Key FDA Decisions Expected in November and December

4 Key FDA Decisions Expected in November and December

Submitted by admin on November 1, 2015 - 11:17am
Source: 
24/7 Wall St
News Tags: 
FDA
Androxal
Repros Therapeutics
elvitegravir
cobicistat
emtricitabine
tenofovir alafenamide
OPuS-2
Biocryst
Synergy Pharmaceuticals
plecanatide
Headline: 
4 Key FDA Decisions Expected in November and December

Do Not Allow Advertisers to Use My Personal information